Financhill
Back

Brainstorm Cell Therapeutics Vs. First Solar Industry Stock Comparison

Sell
30

BCLI
Brainstorm Cell Therapeutics

Last Price:
0.35
Seasonality Move:
27.17%
Sell
46

FSLR
First Solar

Last Price:
216.83
Seasonality Move:
5.16%
Sell
30
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $0.36. The Score for BCLI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
First Solar (FSLR) is a Sell

Is First Solar a Buy, Sell or Hold?

  • The current First Solar [FSLR] share price is $222.71. The Score for FSLR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FSLR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight buying pressure.

FSLR Stock Price Chart

What is First Solar's stock price today?

  • The First Solar share price today is $222.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FSLR is experiencing slight buying pressure.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 37.85 Sell
Chaikin Money Flow: 199201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.38 - 0.48) Sell
Bollinger Bands (100): (0.35 - 0.57) Sell

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: 785027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (249.45 - 285.19) Sell
Bollinger Bands (100): (148.41 - 241.45) Buy

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.41 Sell
50-day SMA: 0.46 Sell
200-day SMA: 0.38 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.41 Sell
50-day EMA: 0.45 Sell
200-day EMA: 0.66 Sell

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 247.85 Sell
20-day SMA: 264.97 Sell
50-day SMA: 229.74 Sell
200-day SMA: 174.81 Buy
8-day EMA: 244.7 Sell
20-day EMA: 252.76 Sell
50-day EMA: 234.55 Sell
200-day EMA: 190.97 Buy

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.

First Solar Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.82 per share, an increase next quarter of $0.92 per share, an increase this year of $5.78 per share, and an increase next year of $8.27 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Solar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):